TGEX-LC-dL-Zeo

MX051

Price (USD): $689.00
+

TGEX-LC-dL-Zeo

Dog Lambda Light Chain Mammalian Expression Vector

Technical Description

The TGEX vector series is designed for the rapid expression of antibody molecules by transient gene expression in mammalian cell suspension cultures. TGEX™-LC-dL-Zeo  expresses the constant region of the dog Lambda light chain. Expression of full length antibody molecules is achieved by co-transfection with a heavy chain variable region cloned into one of the TGEX™-HC vector series. Using transient transfection technologies yields of antibody between 20 mg/L and 200 mg/L and more in serum-free conditions can be obtained in just a few days.

Applications

  • Mammalian expression of full length antibodies by transient gene expression.

  • Selection of stable transfectants using Zeocin™.

For research use only; not intended for any animal or human therapeutic or diagnostic use.

Specifications

General Characteristics:

Plasmid Size: 5156
Promoter: CMV + TPL
Leader Peptide: pelBK
Cloning Site: Double BsaI
Fusion Protein: dog Lambda constant region
Selection: ampicillin (bacteria), zeocin™ (mammalian)
Replication: pMB1 high copy number

Physical Characteristics:

Concentration: 0.5 µg/µl.
Product Size: 10 µg.
Buffer: DNA Conservation Buffer (Tris/HCL 5 mM, EDTA 0.1 mM, pH 8.5, sterile).
Storage Temperature: -20°C.

Quality Control & Certification of Analysis

Product Sequence:

The entire plasmid sequence was confirmed by the Sanger method.

Certification:

Product meets all specifications.

TGEX-LC-dL-Zeo map

 

TGEX-LC-dL-Zeo cloning site

 

Citations

  1. Ko HL, Lee DK, Kim Y, Jang HJ, Lee YW, Lee HY, Seok SH, Park JW, Limb JK, On DI, Yun JW, Lyoo KS, Song D, Yeom M, Lee H, Seong JK, Lee S. (2023). Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants. Virol J. 2023;20(1):285.

  2. Mendoza-Salazar I., Gómez-Castellano KM., González-González E., Gamboa-Suasnavart R., Rodríguez-Luna SD., Santiago-Casas G., Cortés-Paniagua MI., Pérez-Tapia SM., Almagro JC. (2022). Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library. Antibodies (Basel),10;11(1):13.

  3. Pedraza-Escalona M., Guzmán-Bringas O., Arrieta-Oliva HI., Gómez-Castellano K., Salinas-Trujano J., Torres-Flores J., Muñoz-Herrera JC., Camacho-Sandoval R., Contreras-Pineda P., Chacón-Salinas R., Pérez-Tapia SM, Almagro JC. (2021). Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. BMC Infect Dis.,30;21(1):1121.

  4. Mukherjee A., Stathos ME., Varner C., Arsiwala A., Frey S., Hu Y., Smalley DM., Schaffer DV., Kane RS. (2020). One-pot synthesis of heterodimeric agonists that activate the canonical Wnt signaling pathway. Chem. Commun. (Camb) 56(25):3685-3688.